Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Extraprostatic Extension of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important?

Gupta R, O'Connell R, Haynes AM, Stricker PD, Barrett W, Turner JJ, Delprado W, Horvath LG, Kench JG.

BJU Int. 2014 Aug 19. doi: 10.1111/bju.12911. [Epub ahead of print]

PMID:
25138271
[PubMed - as supplied by publisher]
2.

Expression of phosphorylated-mTOR during the development of prostate cancer.

Sutherland SI, Pe Benito R, Henshall SM, Horvath LG, Kench JG.

Prostate. 2014 Jul 7. doi: 10.1002/pros.22840. [Epub ahead of print]

PMID:
25043667
[PubMed - as supplied by publisher]
3.

5-Alpha reductase inhibitors and PSA screening for prostate cancer.

McKenzie PR, Delahunt B, Kench JG, Sikaris KA.

Pathology. 2014 Jan;46(1):91-2. doi: 10.1097/PAT.0000000000000041. No abstract available.

PMID:
24300730
[PubMed - in process]
4.

Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.

Yip PY, Cooper WA, Kohonen-Corish MR, Lin BP, McCaughan BC, Boyer MJ, Kench JG, Horvath LG.

J Clin Pathol. 2014 Apr;67(4):333-40. doi: 10.1136/jclinpath-2013-201870. Epub 2013 Nov 21.

PMID:
24265323
[PubMed - indexed for MEDLINE]
5.

Adjuvant chemotherapy in elderly patients with pancreatic cancer.

Nagrial AM, Chang DK, Nguyen NQ, Johns AL, Chantrill LA, Humphris JL, Chin VT, Samra JS, Gill AJ, Pajic M; Australian Pancreatic Cancer Genome Initiative, Pinese M, Colvin EK, Scarlett CJ, Chou A, Kench JG, Sutherland RL, Horvath LG, Biankin AV.

Br J Cancer. 2014 Jan 21;110(2):313-9. doi: 10.1038/bjc.2013.722. Epub 2013 Nov 21.

PMID:
24263063
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The dilemmas of prostate cancer screening.

McKenzie PR, Delahunt B, Kench JG.

Med J Aust. 2013 Nov 4;199(9):582. No abstract available.

PMID:
24182214
[PubMed - indexed for MEDLINE]
7.

Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27.

Young JA, Ting KK, Li J, Moller T, Dunn L, Lu Y, Moses J, Prado-Lourenço L, Khachigian LM, Ng M, Gregory PA, Goodall GJ, Tsykin A, Lichtenstein I, Hahn CN, Tran N, Shackel N, Kench JG, McCaughan G, Vadas MA, Gamble JR.

Blood. 2013 Oct 17;122(16):2911-9. doi: 10.1182/blood-2012-12-473017. Epub 2013 Sep 5.

PMID:
24009229
[PubMed - indexed for MEDLINE]
8.

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.

Cooper WA, Yu B, Yip PY, Ng CC, Lum T, Farzin M, Trent RJ, Mercorella B, Clarkson A, Kohonen-Corish MR, Horvath LG, Kench JG, McCaughan B, Gill AJ, O'Toole SA.

J Clin Pathol. 2013 Sep;66(9):744-8. doi: 10.1136/jclinpath-2013-201607. Epub 2013 Jun 11.

PMID:
23757037
[PubMed - indexed for MEDLINE]
9.

Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.

Gzell CE, Kench JG, Stockler MR, Hruby G.

Int Urol Nephrol. 2013 Jun;45(3):735-42. doi: 10.1007/s11255-013-0462-7. Epub 2013 May 11. Review.

PMID:
23666549
[PubMed - indexed for MEDLINE]
10.

Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.

McKenzie PR, Delahunt B, Kench JG, Ross B, Lam Q, deVoss K, Tran HA, Sikaris KA.

Pathology. 2013 Jun;45(4):343-5. doi: 10.1097/PAT.0b013e3283619a77. No abstract available.

PMID:
23619589
[PubMed - indexed for MEDLINE]
11.

Classification, morphology and molecular pathology of premalignant lesions of the pancreas.

Cooper CL, O'Toole SA, Kench JG.

Pathology. 2013 Apr;45(3):286-304. doi: 10.1097/PAT.0b013e32835f2205. Review.

PMID:
23442735
[PubMed - indexed for MEDLINE]
12.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Apr 1;31(10):1348-56. doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25.

PMID:
23439753
[PubMed - indexed for MEDLINE]
Free Article
13.

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

Yip PY, Yu B, Cooper WA, Selinger CI, Ng CC, Kennedy CW, Kohonen-Corish MR, McCaughan BC, Trent RJ, Boyer MJ, Kench JG, Horvath LG, O'Toole SA.

J Thorac Oncol. 2013 Apr;8(4):408-14. doi: 10.1097/JTO.0b013e318283558e.

PMID:
23392229
[PubMed - indexed for MEDLINE]
14.

Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.

Kench JG, Delahunt B, Griffiths DF, Humphrey PA, McGowan T, Trpkov K, Varma M, Wheeler TM, Srigley JR.

Histopathology. 2013 Jan;62(2):203-18. doi: 10.1111/his.12042. Review.

PMID:
23240714
[PubMed - indexed for MEDLINE]
15.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N; Australian Pancreatic Cancer Genome Initiative, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM.

Nature. 2012 Nov 15;491(7424):399-405. doi: 10.1038/nature11547. Epub 2012 Oct 24.

PMID:
23103869
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

RON is not a prognostic marker for resectable pancreatic cancer.

Tactacan CM, Chang DK, Cowley MJ, Humphrey ES, Wu J, Gill AJ, Chou A, Nones K, Grimmond SM, Sutherland RL, Biankin AV, Daly RJ; Australian Pancreratic Genome Initiative.

BMC Cancer. 2012 Sep 7;12:395. doi: 10.1186/1471-2407-12-395.

PMID:
22958871
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.

Hulf T, Sibbritt T, Wiklund ED, Patterson K, Song JZ, Stirzaker C, Qu W, Nair S, Horvath LG, Armstrong NJ, Kench JG, Sutherland RL, Clark SJ.

Oncogene. 2013 Jun 6;32(23):2891-9. doi: 10.1038/onc.2012.300. Epub 2012 Aug 6.

PMID:
22869146
[PubMed - indexed for MEDLINE]
18.

The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA.

Nature. 2012 Apr 29;486(7402):266-70. doi: 10.1038/nature11114. Erratum in: Nature. 2013 Feb 21;494(7437):390. Scarlett, Christopher J [added]; Kaplan, Warren [added]; Scarpa, Aldo [added], Das, Amithabad [corrected to Das, Amitabha].

PMID:
22699621
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The prognostic and predictive value of serum CA19.9 in pancreatic cancer.

Humphris JL, Chang DK, Johns AL, Scarlett CJ, Pajic M, Jones MD, Colvin EK, Nagrial A, Chin VT, Chantrill LA, Samra JS, Gill AJ, Kench JG, Merrett ND, Das A, Musgrove EA, Sutherland RL, Biankin AV; NSW Pancreatic Cancer Network.

Ann Oncol. 2012 Jul;23(7):1713-22. doi: 10.1093/annonc/mdr561. Epub 2012 Jan 11.

PMID:
22241899
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Retinoid signaling in pancreatic cancer, injury and regeneration.

Colvin EK, Susanto JM, Kench JG, Ong VN, Mawson A, Pinese M, Chang DK, Rooman I, O'Toole SA, Segara D, Musgrove EA, Sutherland RL, Apte MV, Scarlett CJ, Biankin AV.

PLoS One. 2011;6(12):e29075. doi: 10.1371/journal.pone.0029075. Epub 2011 Dec 29.

PMID:
22220202
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk